We count visits as totals without cookies, and never follow you from one day to the next. If you accept, we also use cookies to see how people use this site, so we can improve it. Privacy policy
Last close (THB)202.00+3.50 (+1.76%)as of 5 Nov 2026
Funds that hold it4One fund per scheme
Held through a master fund04 buy the stock themselves
Largest weight in a single fund18.68%Of that fund's NAV
Median weight9.80%Half the funds hold more than this
What does BH do
Bumrungrad Hospital PCL
Runs a premium private hospital in Bangkok that treats many foreign patients, so revenue depends on international patient numbers and high fees per visit
Bumrungrad HospitalHealth checksHeart and cancer centresInternational patients (medical tourism)Overseas clinics
Where the revenue comes from, and how much is left as profit (FY2025)
For every 100 baht of sales: cost of sales 48 · operating expenses 16 · other income adds 1 · tax and other items 7 · leaving 30 as net profit
Which funds let you invest in BH
Sorted by weight held, largest first
Investors in Thailand can buy BH through 4 mutual funds open to retail investors. Every one of them buys the stock directly.
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
How many funds each AMC holds it through
BBLAM
Data sourcesFunds that buy the stock themselves: top 5 holdings from the AMC's fact sheet as of 30 Sep 2026 · Funds that invest through a master fund: the master fund's portfolio from its issuer's fact sheet or prospectus · Each scheme counts as one fund · Share price: Market data · Financial statements: SEC Thailand (audited financial statements) · Ratios: Market data · Revenue by business segment: SEC Thailand (audited financial statements) · Weights are as of the report date, and funds can change their portfolios at any time · Investing involves risk. This is not investment advice.
Showing 4 of 4 funds you can buy · The full list is in the Expert view · Latest weights from portfolio reports, and funds can change their portfolios at any time · Past performance is not a guarantee of future performance
Valuation and key ratios
Bumrungrad Hospital PCL · SET · Fiscal year ends in December
Market cap160.6B THB0.79 billion shares
P/E23.3xPrice ÷ FY2025 EPS 8.66
Forward P/E19.7xBased on forecast 12-month earnings
P/S6.7x
EV/EBITDA14.3x
Dividend yield6.44%13.00 THB per share a year
ROE25.7%Net profit ÷ shareholders' equity
Debt to equity (D/E)0.00xInterest-bearing debt
Beta0.84Against SET50 (TDEX fund)
Gross margin51.8%FY2025
Operating margin36.9%FY2025
Net margin29.8%FY2025
Price ratios use the latest close shown on this page · Forward P/E, P/S and EV/EBITDA from Market data · Beta from 5 years of monthly returns · Total dividends over the last 12 months
Company health made simple
From the FY2025 statements
Sales growth6.8%Steady growth
Yearly average over the last 3 years · Latest annual sales 25.2B THB
Profit from sales30%Highly profitable
For every 100 baht of sales, about 30 baht is left as net profit
Dividend6.44%Pays dividends
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
1-year share price+13.8%Up
Now 5.2% below its 1-year high
A rise or fall in the share price doesn't move a fund by the same amount — a fund is affected only in proportion to how much it holds
Financial statements
Revenue grows 6.8% a year on average · EPS grows 15.0% a year on average
Annual · last 4 fiscal years
Revenue and net profit
FY202220.7B THB4.9B THB
FY202325.4B THB7.0B THB
FY202425.7B THB7.8B THB
FY202525.2B THB7.5B THB
Total revenue
Net profit
Quarterly · last 5 quarters
Revenue and net profit
Q2 FY20256.0B THB1.9B THB
Q3 FY20256.5B THB2.0B THB
Q4 FY20256.5B THB1.9B THB
Q1 FY20266.2B THB1.8B THB
Q2 FY20266.3B THB1.9B THB
Annual income statement, balance sheet and cash flow
Item (THB)
FY2022
FY2023
FY2024
FY2025
Total revenue
20.7B THB
25.4B THB
25.7B THB
25.2B THB
Gross profit
9.6B THB
12.5B THB
13.2B THB
13.1B THB
Operating profit
6.1B THB
8.6B THB
9.4B THB
Free cash flow = operating cash flow − capital expenditure · A cell showing N/A is an item the statement doesn't report, not a zero · Source: SEC Thailand (audited financial statements)
Technical analysis
Closed at 202.00 THB on 5 Nov 2026
Daily trendClear uptrendScore 1.00 on a scale of −1 to +1 · 1211 bars
RSI(14)
60.3
ADX(14)
24.0
Position in the price range
83%
Weekly trendClear uptrendScore 0.90 on a scale of −1 to +1 · 262 bars
RSI(14)
59.9
ADX(14)
20.9
Position in the price range
86%
Monthly trendLeaning upScore 0.33 on a scale of −1 to +1 · 61 bars
RSI(14)
54.1
ADX(14)
17.1
Position in the price range
48%
Moving averages (daily)
Period
SMA
EMA
Price vs line
10 days
199.60
198.51
Above
20 days
194.63
196.76
Above
50 days
195.38
194.56
Above
100 days
191.53
190.92
Above
200 days
Indicators (daily)
Indicator
Value
Signal
RSI(14)
60.27
Up
MACD(12,26)
1.87
Up
ADX(14)
24.02
Neutral
ATR(14) % of price
1.09
Neutral
Support and resistance (weekly pivots)
s3192
s2194
s1
Trend score = average of the moving-average group and the indicator group ((up signals − down signals) ÷ number of signals) · RSI and ATR use Wilder's method · MACD uses the 12- and 26-period EMA · An ADX of 25 or above counts as a clear trend · Calculated from daily closing prices from Market data · Not investment advice
One fund counted per scheme · Funds investing through a master fund show the master fund's weight in BH, not the look-through weight · Past performance is not a guarantee of future performance